Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin
- Status
- TERMINATED
- Phase
- PHASE2
Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy of Neoadjuvant Folfirinox Regimen in Patients With Resectable Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of Stomach
- Status
- UNKNOWN
- Phase
- PHASE2
Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
XEBRA Study: An Observational Study of Xeloda (Capecitabine) in Combination With Docetaxel in First Line in Participants With HER2-Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Chemoradiotherapy for Patients With Oligometastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
GTX-RT in Borderline Resectable Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab With Chemoradiotherapy in the Adjuvant Setting in Operated Participants With Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Gastric or Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
An Observational Study of Xeloda (Capecitabine) in Participants With Metastatic or Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Optimization of Bevacizumab Scheduling With Chemotherapy for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3